DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/vcv69x/urinary_tract) has announced the addition of the "Urinary Tract Infections - Pipeline Review, H2 2013" report to their offering.
'Urinary Tract Infections - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Urinary Tract Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Urinary Tract Infections.
Reasons to buy
- Identify and understand important and diverse types of therapeutics under development for Urinary Tract Infections. Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
- Devise corrective measures for pipeline projects by understanding Urinary Tract Infections pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.
Companies Involved in Urinary Tract Infections Therapeutics Development
- Shionogi & Co., Ltd.
- AstraZeneca PLC
- Merck & Co., Inc.
- Cubist Pharmaceuticals, Inc.
- Nippon Shinyaku Co., Ltd.
- Toyama Chemical Co. Ltd
- Paratek Pharmaceuticals, Inc.
- NovaBay Pharmaceuticals, Inc.
- Nymox Pharmaceutical Corporation
- Plethora Solutions Holdings plc
- CytoTools AG
- Achaogen Inc.
- MerLion Pharmaceuticals Pte Ltd
- ConjuGon, Inc.
- Osel Inc.
- Pinnacle Pharmaceuticals, Inc.
- Sequoia Sciences, Inc.
- Tetraphase Pharmaceuticals Inc.
For more information visit http://www.researchandmarkets.com/research/vcv69x/urinary_tract
